Literature DB >> 15520861

A viral epitope that mimics a self antigen can accelerate but not initiate autoimmune diabetes.

Urs Christen1, Kurt H Edelmann, Dorian B McGavern, Tom Wolfe, Bryan Coon, Meghann K Teague, Stephen D Miller, Michael B A Oldstone, Matthias G von Herrath.   

Abstract

We document here that infection of prediabetic mice with a virus expressing an H-2Kb-restricted mimic ligand to a self epitope present on beta cells accelerates the development of autoimmune diabetes. Immunization with the mimic ligand expanded autoreactive T cell populations, which was followed by their trafficking to the islets, as visualized in situ by tetramer staining. In contrast, the mimic ligand did not generate sufficient autoreactive T cells in naive mice to initiate disease. Diabetes acceleration did not occur in H-2Kb-deficient mice or in mice tolerized to the mimic ligand. Thus, arenavirus-expressed mimics of self antigens accelerate a previously established autoimmune process. Sequential heterologous viral infections might therefore act in concert to precipitate clinical autoimmune disease, even if single exposure to a viral mimic does not always cause sufficient tissue destruction.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15520861      PMCID: PMC524231          DOI: 10.1172/JCI22557

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  50 in total

Review 1.  T-cell receptor crossreactivity and autoimmune disease.

Authors:  H Cantor
Journal:  Adv Immunol       Date:  2000       Impact factor: 3.543

2.  Virus-induced diabetes in a transgenic model: role of cross-reacting viruses and quantitation of effector T cells needed to cause disease.

Authors:  N Sevilla; D Homann; M von Herrath; F Rodriguez; S Harkins; J L Whitton; M B Oldstone
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

3.  Acceleration of type 1 diabetes by a coxsackievirus infection requires a preexisting critical mass of autoreactive T-cells in pancreatic islets.

Authors:  D V Serreze; E W Ottendorfer; T M Ellis; C J Gauntt; M A Atkinson
Journal:  Diabetes       Date:  2000-05       Impact factor: 9.461

4.  Monoclonal antibodies to lymphocytic choriomeningitis and pichinde viruses: generation, characterization, and cross-reactivity with other arenaviruses.

Authors:  M J Buchmeier; H A Lewicki; O Tomori; M B Oldstone
Journal:  Virology       Date:  1981-08       Impact factor: 3.616

5.  Association between rotavirus infection and pancreatic islet autoimmunity in children at risk of developing type 1 diabetes.

Authors:  M C Honeyman; B S Coulson; N L Stone; S A Gellert; P N Goldwater; C E Steele; J J Couper; B D Tait; P G Colman; L C Harrison
Journal:  Diabetes       Date:  2000-08       Impact factor: 9.461

6.  Virus-induced autoimmune diabetes: most beta-cells die through inflammatory cytokines and not perforin from autoreactive (anti-viral) cytotoxic T-lymphocytes.

Authors:  S Seewaldt; H E Thomas; M Ejrnaes; U Christen; T Wolfe; E Rodrigo; B Coon; B Michelsen; T W Kay; M G von Herrath
Journal:  Diabetes       Date:  2000-11       Impact factor: 9.461

7.  Multiple sclerosis in the Faroe Islands: I. Clinical and epidemiological features.

Authors:  J F Kurtzke; K Hyllested
Journal:  Ann Neurol       Date:  1979-01       Impact factor: 10.422

8.  The third signal in T cell-mediated autoimmune disease?

Authors:  Kamruz Darabi; Alexey Y Karulin; Bernhard O Boehm; Harald H Hofstetter; Zsuzsa Fabry; Joseph C LaManna; Juan C Chavez; Magdalena Tary-Lehmann; Paul V Lehmann
Journal:  J Immunol       Date:  2004-07-01       Impact factor: 5.422

9.  Serum immunoreactive trypsin concentrations in infectious and non-infectious illnesses and in juvenile diabetes.

Authors:  D R Gamble; A Moffatt; V Marks
Journal:  J Clin Pathol       Date:  1979-09       Impact factor: 3.411

10.  The induction of cell-mediated immunity and tolerance with protein antigens coupled to syngeneic lymphoid cells.

Authors:  S D Miller; R P Wetzig; H N Claman
Journal:  J Exp Med       Date:  1979-03-01       Impact factor: 14.307

View more
  52 in total

Review 1.  Heterologous immunity between viruses.

Authors:  Raymond M Welsh; Jenny W Che; Michael A Brehm; Liisa K Selin
Journal:  Immunol Rev       Date:  2010-05       Impact factor: 12.988

Review 2.  Infection as a cause of type 1 diabetes?

Authors:  Urs Christen; Christine Bender; Matthias G von Herrath
Journal:  Curr Opin Rheumatol       Date:  2012-07       Impact factor: 5.006

Review 3.  Pathogenesis of type 1 diabetes mellitus: interplay between enterovirus and host.

Authors:  Didier Hober; Pierre Sauter
Journal:  Nat Rev Endocrinol       Date:  2010-03-30       Impact factor: 43.330

Review 4.  Virus infections in type 1 diabetes.

Authors:  Ken T Coppieters; Tobias Boettler; Matthias von Herrath
Journal:  Cold Spring Harb Perspect Med       Date:  2012-01       Impact factor: 6.915

5.  Anti-CD3 and nasal proinsulin combination therapy enhances remission from recent-onset autoimmune diabetes by inducing Tregs.

Authors:  Damien Bresson; Lisa Togher; Evelyn Rodrigo; Yali Chen; Jeffrey A Bluestone; Kevan C Herold; Matthias von Herrath
Journal:  J Clin Invest       Date:  2006-04-20       Impact factor: 14.808

Review 6.  The two faces of heterologous immunity: protection or immunopathology.

Authors:  Shalini Sharma; Paul G Thomas
Journal:  J Leukoc Biol       Date:  2013-11-08       Impact factor: 4.962

Review 7.  Molecular mimicry, bystander activation, or viral persistence: infections and autoimmune disease.

Authors:  Robert S Fujinami; Matthias G von Herrath; Urs Christen; J Lindsay Whitton
Journal:  Clin Microbiol Rev       Date:  2006-01       Impact factor: 26.132

8.  Type 1 diabetes and hypoglycemia.

Authors:  Zachary T Bloomgarden
Journal:  Diabetes Care       Date:  2009-01       Impact factor: 19.112

9.  Enterovirus infection of human beta-cells activates dendritic cells and triggers innate antiviral responses: are enteroviruses convicted now?

Authors:  Urs Christen
Journal:  Diabetes       Date:  2010-05       Impact factor: 9.461

10.  Interaction of Cowpea mosaic virus (CPMV) nanoparticles with antigen presenting cells in vitro and in vivo.

Authors:  Maria J Gonzalez; Emily M Plummer; Chris S Rae; Marianne Manchester
Journal:  PLoS One       Date:  2009-11-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.